Filing Details
- Accession Number:
- 0001368148-21-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-17 18:26:40
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-17 18:26:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402605 | K Laura Campbell | 3201 Carnegie Avenue Cleveland OH 44115-2634 | Senior Vice Pres Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-17 | 9,548 | $1.95 | 413,692 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-03-16 | 10,000 | $1.97 | 403,692 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation.
- Shares sold pursuant to a previously established and predefined Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $1.985, inclusive, in accordance with a previously established and predefined Rule 10b5-1 trading plan.
- Securities beneficially owned are comprised of (1) 273,925 shares of common stock owned and (2) unvested restricted stock units aggregating 129,767 related to annual awards, which vest quarterly over a three or four-year period from date of grant.